Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action

American Journal of Physiology - Endocrinology and Metabolism

Volumn 277, Issue 2 40-2, 1999, Pages

  Barzilai, Nir ^a   She, Li ^a   Liu, Lisen ^a   Wang, Jiali ^a   Hu, Meizu ^a   Vuguin, Patricia ^a   Rossetti, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 3 ADRENERGIC RECEPTOR; INSULIN; LEPTIN;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DIET RESTRICTION; GLUCONEOGENESIS; INSULIN SENSITIVITY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; VISCERA;

EID: 0032828345     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.277.2.e291     Document Type: Article

References (46)

1. Bai, Y., S. Zhang, K.-S. Kim, J.-K. Lee, and K.-H. Kim. Leptin inhibits acetyl-CoA carboxylase in 3T3 pre-adipocytes. J. Biol. Chem. 271: 13939-13942, 1996.
2. Barzilai, N., S. Banerjee, M. Hawkins, W. Chen, and L. Rossetti. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J. Clin. Invest. 101: 1353-1361, 1998.
3. Barzilai, N., D. Massillon, and L. Rossetti. Effects of fasting on hepatic and peripheral glucose metabolism in conscious rats with near-total fat depletion. Biochem. J. 310: 819-826, 1995.
4. Barzilai, N., and L. Rossetti. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J. Biol. Chem. 268: 25019-25025, 1993.
5. Barzilai, N., and L. Rossetti. Age-related changes in body composition are associated with hepatic insulin resistance in conscious rats. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E930-E936, 1996.
6. Barzilai, N., L. She, B.-Q. Liu, M. Hu, and L. Rossetti. Surgical removal of visceral fat (VF) in rats reverses hepatic insulin resistance. Diabetes 48: 341-345, 1999.
7. Barzilai, N., J. Wang, D. Massilon, P. Vuguin, M. Hawkins, and L. Rossetti. Leptin selectively decreases visceral adiposity and enhances insulin action. J. Clin. Invest. 100: 3105-3110, 1997.
8. Bessard, T., Y. Schutz, and E. Jequier. Energy expenditure and postprandial thermogenesis in obese women before and after weight loss. Am. J. Clin. Nutr. 38: 680-693, 1983.
9. Bjorntorp, P. Metabolic implications of body fat distribution. Diabetes Care 14: 1132-1143, 1991.
10. Clement, K., C. Vaisse, B. S. Manning, A. Basdevant, B. Guy-Grand, J. Ruiz, K. D. Silver, A. R. Shuldiner, P. Froguel, and A. D. Strosberg. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333: 352-354, 1995.
11. Cohen, B., D. Novick, and M. Rubinstein. Modulation of insulin activities by leptin. Science 274: 1185-1188, 1996.
12. Cusin, I., K. E. Zakrzewska, O. Boss, P. Muzzin, J.-P. Giacobino, D. Ricquier, B. Jeanrenaud, and F. Rhohner-Jeanrenaud. Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 47: 1014-1019, 1998.
13. Diaz, E. O., A. M. Prentice, G. R. Goldberg, P. R. Murgatroyd, and W. A. Coward. Metabolic response to experimental overfeeding in overweight healthy volunteers. Am. J. Clin. Nutr. 56: 641-655, 1992.
14. Feinstein, R., H. Kanety, M. S. Papa, B. Lunenfeld, and A. Karasic. Tumor necrosis factor-a supresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 268: 26055-26057, 1993.
15. Felber, J. P., E. Ferrannini, A. Golay, H. U. Meyer, D. Thiebaud, and R. A. Defronzo. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36: 1341-1350, 1987.
16. Flatt, J. P. Dietary fat, carbohydrate balance, and weight maintenance: effect of exercise. Am. J. Clin. Nutr. 45: 296-306, 1987.
17. Flier, J. S. Leptin expression and action: new experimental paradigms. Proc. Natl. Acad. Sci. USA 94: 4242-4245, 1997.
18. Gettys, T. W., P. J. Harkness, and P. M. Watson. The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 137: 4054-4057, 1996.
19. Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabinowitz, R. L. Lallone, S. K. Burley, and J. M. Friedman. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
20. 3-agonist, on energy balance and brown and white adipose tissues in rats. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1371-R1382, 1994.
21. Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
22. Kamohara, S., R. Burcelin, J. L. Halaas, J. M. Friedman, and M. J. Charron. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377, 1997.
23. Kellerer, M., M. Koch, E. Metzinger, J. Mushack, E. Capp, and H. U. Haring. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40: 1353-1362, 1997.
24. Kim, Y.-B., S. Uotani, J. S. Flier, and B. B. Kahn. In vivo administration of leptin rapidly activates PI3-kinase in insulin sensitive tissues. Diabetes 47, Suppl. 1: 1226, 1998.
25. Kissebah, A. H. Insulin resistance in visceral obesity. Int. J. Obes. 15, Suppl. 2: 109-115, 1991.
26. Krief, S., F. Lonnqvist, S. Raimbault, B. Baude, A. Van Spronsen, P. Arner, A. D. Strosberg, D. Ricquier, and L. J. Emorine. Tissue distribution of beta 3-adrenergic receptor mRNAin man. J. Clin. Invest. 91: 344-349, 1993.
27. Larson, B. Regional obesity as health hazard in men -prospective studies. Acta Med. Scand. 723: 45-51, 1992.
28. 3-Adrenergic-mediated suppression of leptin gene expression in rats. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E1031-E1036, 1997.
29. Liu, L., G. Karkanias, J. Morales, M. Hawkins, N. Barzilai, J. Wang, and L. Rossetti. Intracerebroventricular (ICV) leptin regulates hepatic but not peripheral glucose fluxes. J. Biol. Chem. 273: 31160-31167, 1998.
30. Mantzoros, C. S., D. Qu, R. C. Frederich, V. S. Susulic, B. B. Lowell, E. Maratos-Flier, and J. S. Flier. Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 45: 909-914, 1996.
31. Massillon, D., N. Barzilai, M. Hawkins, D. Prus-Wertheimer, and L. Rossetti. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46: 153-157, 1997.
32. Muoio, D. M., G. L. Dohn, F. T. Fiedorek, E. B. Tapscott, and R. A. Coleman. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46: 1360-1363, 1997.
33. Pan, D. A., S. Lillioja, A. D. Kriketos, M. R. Milner, L. A. Baur, C. Bogardus, A. B. Jenkins, and L. H. Storlien. Skeletal muscle triglyceride levels are inversely related to insulin. Diabetes 46: 983-988, 1997.
34. Pelleymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
35. Rebrin, K., G. M. Steil, S. D. Mittelman, and R. N. Bergman. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98: 741-749, 1996.
36. Rossetti, L., N. Barzilai, W. Chen, T. Harris, D. Yang, and C. E. Rogler. Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J. Biol. Chem. 271: 203-208, 1996.
37. Rossetti, L., and A. Giaccari. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J. Clin. Invest. 85: 1785-1792, 1990.
38. Rossetti, L., A. Giaccari, N. Barzilai, K. Howard, G. Sebel, and M. Hu. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J. Clin. Invest. 92: 1126-1134, 1993.
39. Rossetti, L., D. Massillon, N. Barzilai, P. Vuguin, J. Wu, R. Liu, and J. Wang. Short-term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J. Biol. Chem. 272: 27758-27763, 1997.
40. Sakane, N., T. Yoshida, T. Umekawa, M. Kondo, Y. Sakai, and T. Takahashi. Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 40: 200-204, 1997.
41. Schwartz, M. W., D. G. Baskin, T. R. Bukowski, J. L. Kuijper, D. Foster, G. Lasser, D. E. Prunkard, D. J. Porte, S. C. Woods, R. Seeley, and D. Weigle. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45: 531-535, 1996.
42. Schwartz, M. W., R. J. Seeley, L. A. Campfield, P. Burn, and D. G. Baskin. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98: 1101-1106, 1996.
43. Sivitz, W. I., S. A. Walsh, D. A. Morgan, M. J. Thomas, and W. G. Haynes. Effects of leptin on insulin sensititvity in normal rats. Endocrinology 138: 3395-3401, 1997.
44. Weigle, D. S., T. R. Bukowski, D. C. Foster, S. Holderman, J. M. Kramer, G. Lasser, C. E. Lofton-Day, D. E. Prunkard, C. Raymond, and J. L. Kuijper. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96: 2065-2070, 1995.
45. Zhou, Y. T., M. Shimabukuro, Y. Lee, K. Koyama, M. Higa, T. Ferguson, and R. H. Unger. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes 47: 1904-1909, 1998.
46. Zierath, J. R., E. U. Frevert, J. W. Ryder, P.-O. Berggren, and B. B. Kahn. Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 47: 1-4, 1998.